ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,631.22
0.28%
Dow Jones
40,211.72
0.53%
US Dollar vs MXN
17.74549
0.08%
Brent Oil
83.54
-0.95%
Bitcoin
63,447.23
-2.17%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Nkarta Inc (NKTX)

  7. Nkarta Inc (NKTX) Noticias

NKTX

Nkarta (NKTX)

Nkarta Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:NKTX
FechaHoraFuenteTítuloSímboloCompañía
11/05/202315:20Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NKTXNkarta Inc
11/05/202315:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NKTXNkarta Inc
11/05/202315:02GlobeNewswire Inc.Nkarta Reports First Quarter 2023 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
11/05/202315:01GlobeNewswire Inc.Nkarta to Present NKX019 Phase 1 Dose Escalation Data at European Hematology Association 2023 Congress and 17th International Conference on Malignant LymphomaNASDAQ:NKTXNkarta Inc
24/04/202316:21Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:NKTXNkarta Inc
24/04/202315:26Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:NKTXNkarta Inc
24/04/202315:18Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NKTXNkarta Inc
17/04/202316:01GlobeNewswire Inc.Nkarta Presents Preclinical Data Exploring Gene Knockout Strategies and Combination Agents with NK Cell-Based Therapies at the 2023 AACR Annual MeetingNASDAQ:NKTXNkarta Inc
14/04/202316:01Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:NKTXNkarta Inc
12/04/202320:06GlobeNewswire Inc.Nkarta to Participate at Upcoming Investor ConferencesNASDAQ:NKTXNkarta Inc
30/03/202315:01GlobeNewswire Inc.Nkarta Announces Departure of Chief Financial & Business OfficerNASDAQ:NKTXNkarta Inc
16/03/202316:03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NKTXNkarta Inc
16/03/202315:01GlobeNewswire Inc.Nkarta Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
14/02/202316:17Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NKTXNkarta Inc
14/02/202307:51Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NKTXNkarta Inc
10/02/202311:08Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NKTXNkarta Inc
09/01/202315:30GlobeNewswire Inc.Nkarta Promotes David R. Shook, M.D., to Chief Medical OfficerNASDAQ:NKTXNkarta Inc
09/01/202315:15Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NKTXNkarta Inc
06/12/202222:25TipRanksSVB Securities Reaffirms Their Buy Rating on Nkarta (NKTX)NASDAQ:NKTXNkarta Inc
05/12/202220:45TipRanksMizuho Securities Remains a Buy on Nkarta (NKTX)NASDAQ:NKTXNkarta Inc
05/12/202214:15TipRanksNeedham Keeps Their Buy Rating on Nkarta (NKTX)NASDAQ:NKTXNkarta Inc
05/12/202210:25TipRanksNkarta (NKTX) Gets a Buy from H.C. WainwrightNASDAQ:NKTXNkarta Inc
05/12/202206:02GlobeNewswire Inc.Nkarta Announces Updated Clinical Data on Anti-CD19 Allogeneic CAR-NK Cell Therapy NKX019 for Patients with Relapsed or Refractory Non-Hodgkin LymphomaNASDAQ:NKTXNkarta Inc
02/12/202215:02GlobeNewswire Inc.Nkarta to Host Conference Call to Discuss Updated Clinical Data from NKX019 NK Cell Therapy ProgramNASDAQ:NKTXNkarta Inc
13/11/202221:56TipRanksNkarta (NKTX) Gets a Buy from SVB SecuritiesNASDAQ:NKTXNkarta Inc
09/11/202219:15TipRanksNkarta (NKTX) Receives a Buy from Mizuho SecuritiesNASDAQ:NKTXNkarta Inc
09/11/202215:02GlobeNewswire Inc.Nkarta Reports Third Quarter 2022 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
07/11/202207:52GlobeNewswire Inc.Nkarta Presents Data Supporting Engineered NK Cell Based Combination Therapies and Next Generation Commercial-Scale Manufacturing Platform at SITC 37th Annual MeetingNASDAQ:NKTXNkarta Inc
07/10/202217:45Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NKTXNkarta Inc
12/08/202205:26TipRanksH.C. Wainwright Remains a Buy on Nkarta (NKTX)NASDAQ:NKTXNkarta Inc
 Showing the most relevant articles for your search:NASDAQ:NKTX

Su Consulta Reciente

BIT
F31766
Vontobel Financial Produ...
BIT
F17506
Vontobel Financial Produ...
LSE
0VQA
Viking Therapeutics
LSE
EFR
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados